In April, The Leukemia & Lymphoma Society (LLS) was invited to participate in the 2013 Milken Institute Global Conference, where some of the world's most extraordinary people gather to explore solutions to today's most pressing challenges in business, health, government, and education. Speakers included former British Prime Minister Tony Blair, former Vice President Al Gore, Microsoft's Bill Gates, Mexican business magnate Carlos Slim, Senator Harry Reid (D-NV) and Rep. Eric Cantor (R-VA).
Louis DeGennaro, PhD, LLS Chief Mission Officer, joined venture capitalists, pharmaceutical and biotech executives and board members from Faster Cures at three different panel discussions to explore funding options for advancing innovative research. He participated in discussions about why high risk long-term investments are needed to turn medical innovation into new therapies, the two different pathways within the LLS Therapy Acceleration Program, and funding options to support cutting-edge research.
Many participants at the conference expressed their appreciation and support for LLS research. Executive director of Faster Cures Margaret Anderson said, "LLS has been transforming the blood cancer space," while NIH Director Dr Francis Collins conveyed a similar sentiment, "LLS is doing great science. We are so proud of our National Center for Advancing Translational Science partnership with you."
No comments:
Post a Comment